NFKB1 and type 2 diabetes mellitus: Results of the current study indicate NF-κβ/ TLR-4 and SERCA/Ca2+ pathways as potential determinants for the regulation of pancreatic β-cells functioning and, subsequently, tailoring therapeutic targets against T2DM.